Mylan stock has dropped 8.5% today after Mylan (NASDAQ:MYL) was slammed by two prominent US lawmakers.
Coordinated ObstructionThe company, along with two other major pharmaceuticals, is being investigated as part of an ongoing probe by the US House of Representative’s oversight panel into drug prices. The companies were accused of “apparent efforts to stonewall” and “coordinated obstruction” by the chair of the committee, Elijah Cummings, D-Md., and presidential hopeful Senator Bernie Sanders. It compounds a poor month for Mylan stock, which dropped as much as 15% in the first week of August trading following the ...
Read The Full Article On StreetSignals.com
Get the latest stock market news on StreetSignals. Follow public companies and get free stock research reports and stock market analysis data and stock tips.
All content provided by StreetSignals is subject to our Terms Of Use and Disclaimer.